Eric Yu serves as the Medical Lead for Neuromuscular Diseases at Biogen, overseeing medical strategy and operations for the Hong Kong affiliate since February 2021. Prior experience includes roles at MSD where Eric managed cancer immunotherapy marketing strategies and at Roche, where responsibilities spanned key account management and regional medical management, focusing on oncology and genomic profiling across the Asia-Pacific region. Eric's academic background includes a PhD in Molecular Pathology from UC San Diego and a strong foundation in biological sciences from The Hong Kong University of Science and Technology, where Eric earned both a Master of Philosophy and a Bachelor of Science in Biochemistry.
This person is not in any teams
This person is not in any offices